Difference between revisions of "Part:BBa K2599015"
Line 95: | Line 95: | ||
<div style="width:35%; padding-left: 33%;"><p style="padding-top: 10px; font-size: 10px; text-align: center;"><b>Figure 7.</b> Bar diagram that showed percentage resistance of Durancin TW-49M (19.52%) to Bacillus subtilis after 4 hours.</p></div> | <div style="width:35%; padding-left: 33%;"><p style="padding-top: 10px; font-size: 10px; text-align: center;"><b>Figure 7.</b> Bar diagram that showed percentage resistance of Durancin TW-49M (19.52%) to Bacillus subtilis after 4 hours.</p></div> | ||
+ | |||
+ | |||
+ | <b>Dose Response Assessment</b> | ||
+ | |||
+ | We diluted samples into three different concentration, which is 0.5, 0.25 and 0.125 times of primitive samples. The positive control in this experiment is Ampicillin and the negative control is <i>Bacillus subtilis</i> without adding bacteriocins. All the data are triplicated and normalized. | ||
+ | |||
+ | |||
+ | |||
+ | {{#tag:html|<img style="width: 60%; padding-left: 20%;" src="https://static.igem.org/mediawiki/2018/9/91/T--NCTU_Formosa--Dur_dose.png" alt="" />}} | ||
+ | <div style="width:50%; padding-left: 25%;"><p style="padding-top: 10px; font-size: 10px; text-align: center;"><b>Figure 8.</b> Bar diagram that showed dose response of Durancin TW-49M after 4 hours.</p></div> | ||
Line 110: | Line 120: | ||
{{#tag:html|<img style="width: 30%; padding-left: 35%;" src="https://static.igem.org/mediawiki/2018/3/33/T--NCTU_Formosa--Dur_safety_plate.png" alt="" />}} | {{#tag:html|<img style="width: 30%; padding-left: 35%;" src="https://static.igem.org/mediawiki/2018/3/33/T--NCTU_Formosa--Dur_safety_plate.png" alt="" />}} | ||
− | <div style="width:70%; padding-left: 15%;"><p style="padding-top: 10px; font-size: 10px; text-align: center;"><b>Figure | + | <div style="width:70%; padding-left: 15%;"><p style="padding-top: 10px; font-size: 10px; text-align: center;"><b>Figure 9.</b> LB Agar plate of sterilization of Durancin+intein+CBD. (A)Negative control:LB broth. (B)Sterilize for 0 minutes. (C)Sterilize for 15 minutes. (D)Sterilize for 30 minutes. (E)Sterilize for 45 minutes. </p></div> |
Revision as of 12:18, 17 October 2018
T7 Promoter+RBS+Durancin TW-49M+intein+CBD
NCTU_Formosa 2018 designed a composite part encoding the Durancin TW-49M sequence (BBa_K2599007), and then combined with a T7 promoter (BBa_I712074), a lac operator (K1624002), a ribosome binding site (BBa_B0034), intein and chintin binding domain (CBD) (BBa_K1465230). Further information of our peptide can be found on our design page.
Figure 1. Composite part of Durancin TW-49M
Introduction
Durancin TW-49M produced by Enterococcus durans QU 49, is a nonpediocin-like class II bacteriocin without modified amino acid. Enterococcus are highly competitive due to their resistance to wide range of pH and temperature. Therefore, the bacteriocins they produce shows their wide range effectiveness on pathogenic bacteria.
Although there is an intramolecular disulfide bond in durancin TW-49M, it is not crucial for activity, while important for the stability of activity.
Mechanism of Durancin TW-49M
The bacteriocins inhibit their target organisms through pore formation. Though the mechanism of each inhibition is vary from species to species, the general process is conserved. To see more details, please search for our project page.
Figure 2. Mechanism of bacteriocin
Features of Durancin TW-49M
1. Species Specific
Bacteriocins are antimicrobial peptides that will kill or inhibit bcterial strains closely related or non-related to produced bacteria, but will not harm the bacteria themselves by specific immunity proteins. The organisims that Lacticin Z targets including Enterococcus faecalis, Bacillus subtilis, Bacillus coagulans, etc. More target organisms can be found on [http://bactibase.hammamilab.org/BAC159 bactibase].
2. Eco-friendly
Since Durancin TW-49M is a polypeptide naturally produced by bacteria itself and can inhibit other bacteria without much environment impact. It don't pose threat to other organisms like farm animals or humans. Therefore, this toxin will not cause safety problem.
3. Biodegradable
Durancin TW-49M is a short peptide that will degrade in a short time. After degradation, this antibacterial peptide is harmless to our environment.
Peptide Prediction
NCTU_Formosa 2017 had compeleted a [http://2017.igem.org/Team:NCTU_Formosa/Model peptide prediction model] that can predict peptide for new function. In this model, they used scoring card method (SCM) for machine learning. This year, NCTU_Formosa 2018 continued to use the same method for predicting antimicrobial peptide, in order to seek more candidates for our project.
Durancin TW-49M is one of the existing peptides that we predicted to show the function of antimicrobial activity. The score of our prediction is 478.97.
Figure 3. The prediction result of Durancin TW-49M.
Experiment Result
Cloning
We conbined our toxic gene to pSB1C3 backbone by the two restriction sites, EcoRI and SpeI, and conducted PCR to check the size of our part. The Durancin TW-49M sequence length is around 213 b.p. For the composite part, the sequence length should be near at 1257 b.p. There are also some restrictioin sites at the two sides of our target protein, provided for future team to utilize the intein tag.
Figure 4. PCR product
Expressing
We chose E. coli 2566 strain to express our antibacterial peptides. The expression of Durancin TW-49M fused with intein was induced by IPTG in E. coli , and intein-Durancin TW-49M specifically bound to the column through chitin binding domain would be purified.
Figure 5. The mass of Durancin TW-49M is around 35.3 kDa. No.1 is E. coli without transformed plasmid, No.2 is pTXB1 backbone without the target peptide, and No. 6-8 are Durancin TW-49M.
Inhibition Ability Analysis
To verify the fuction of bacteriocins, we target the major bacteria in soil, Bacillus subtilis. Positive control in the experiment is Ampicillin while the negative control is Bacillus subtilis without adding bacteriocins. We record record OD600 values of samples with Elisa Reader. The growth curve of Bacillus subtilis can be observed in our resluts.
Figure 6. Normalized growth curve of Bacillus subtilis that showed Durancin TW-49M inhibiting ability throughout 4 hours.
Figure 7. Bar diagram that showed percentage resistance of Durancin TW-49M (19.52%) to Bacillus subtilis after 4 hours.
Dose Response Assessment
We diluted samples into three different concentration, which is 0.5, 0.25 and 0.125 times of primitive samples. The positive control in this experiment is Ampicillin and the negative control is Bacillus subtilis without adding bacteriocins. All the data are triplicated and normalized.
Figure 8. Bar diagram that showed dose response of Durancin TW-49M after 4 hours.
Safety
In the future, we are going to spray our bio-stimulator into the environment. To make sure whether the bacteria contain anti-microbial peptide will not exist in the final product, we design the processing standards in the laboratory.
Bacteriocins are usually heat stable, we use high-temperature sterilization to double make sure our peptide solution does not contain any living E. coli. However, peptides may degrades after long time sterilization. To find out the best fitted time for sterilization, we boiled our bacteriocins for 0, 15, 30, and 45 minutes, and put them on LB Agar plate and cultured it at 37℃ for 16 hours.
From the result of the plate, we can easily observe that bacteria exists only in the sample that is not boiled. After fifteen minutes of sterilization, there are no alive bacterias exist.
Figure 9. LB Agar plate of sterilization of Durancin+intein+CBD. (A)Negative control:LB broth. (B)Sterilize for 0 minutes. (C)Sterilize for 15 minutes. (D)Sterilize for 30 minutes. (E)Sterilize for 45 minutes.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12INCOMPATIBLE WITH RFC[12]Illegal NheI site found at 1121
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25INCOMPATIBLE WITH RFC[25]Illegal NgoMIV site found at 844
Illegal AgeI site found at 934 - 1000INCOMPATIBLE WITH RFC[1000]Illegal BsaI.rc site found at 764
Reference
1. Hanchi, H., et al. (2018). "The Genus Enterococcus: Between Probiotic Potential and Safety Concerns—An Update." 9(1791).